115 related articles for article (PubMed ID: 10833512)
41. Inhibitory effects of 9-beta-D-arabinofuranosylguanine 5'-triphosphate and 9-beta-D-arabinofuranosyladenine 5'-triphosphate on DNA polymerases from murine cells and oncornavirus.
Ono K; Ohashi A; Yamamoto A; Matsukage A; Takahasi T; Saneyoshi M; Ueda T
Cancer Res; 1979 Nov; 39(11):4673-80. PubMed ID: 91427
[TBL] [Abstract][Full Text] [Related]
42. Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate.
List AF; Kummet TD; Adams JD; Chun HG
Am J Med; 1990 Sep; 89(3):388-90. PubMed ID: 1697447
[No Abstract] [Full Text] [Related]
43. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
Grever MR; Kopecky KJ; Coltman CA; Files JC; Greenberg BR; Hutton JJ; Talley R; Von Hoff DD; Balcerzak SP
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):457-9. PubMed ID: 2464793
[TBL] [Abstract][Full Text] [Related]
44. Chemical and enzymatic synthesis of 4'-thio-beta-D-arabinofuranosylcytosine monophosphate and triphosphate.
Fowler AS; Tiwari KN; Campbell SR; Secrist JA
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):533-7. PubMed ID: 16247985
[TBL] [Abstract][Full Text] [Related]
45. Fludarabine therapy in chronic lymphocytic leukemia (CLL).
Keating MJ; Kantarjian H; Talpaz M; Redman J; McCredie KB
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):461-6. PubMed ID: 2464794
[TBL] [Abstract][Full Text] [Related]
46. Phase I clinical investigation of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate (NSC 312887), a new purine antimetabolite.
Hutton JJ; Von Hoff DD; Kuhn J; Phillips J; Hersh M; Clark G
Cancer Res; 1984 Sep; 44(9):4183-6. PubMed ID: 6204752
[TBL] [Abstract][Full Text] [Related]
47. Chemosensitivity in vitro to 2-chlorodeoxyadenosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in previously unexposed cases of chronic lymphocytic leukemia.
Koski T; Vilpo L; Vilpo J
Leuk Res; 1999 Mar; 23(3):277-9. PubMed ID: 10071081
[TBL] [Abstract][Full Text] [Related]
48. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
49. Metabolism and action of fludarabine phosphate.
Plunkett W; Huang P; Gandhi V
Semin Oncol; 1990 Oct; 17(5 Suppl 8):3-17. PubMed ID: 1699280
[TBL] [Abstract][Full Text] [Related]
50. An exonuclease activity associated with DNA polymerase I of Micrococcus radiodurans.
Kitayama S; Ishizaka Y; Miyai S; Matsuyama A
Biochim Biophys Acta; 1978 Aug; 520(1):122-30. PubMed ID: 698224
[TBL] [Abstract][Full Text] [Related]
51. A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein.
Höss M; Robins P; Naven TJ; Pappin DJ; Sgouros J; Lindahl T
EMBO J; 1999 Jul; 18(13):3868-75. PubMed ID: 10393201
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of DNA synthesis in permeabilized mouse P815 mast cells by arabinofuranosyladenine 5'-triphosphate.
Geurtsen W; Zahn RK; Maidhof A; Schmidseder R; Müller WE
Chemotherapy; 1981; 27(1):61-7. PubMed ID: 6163594
[TBL] [Abstract][Full Text] [Related]
53. Human AP endonuclease possesses a significant activity as major 3'-5' exonuclease in human leukemia cells.
Yoshida A; Ueda T
Biochem Biophys Res Commun; 2003 Oct; 310(2):522-8. PubMed ID: 14521941
[TBL] [Abstract][Full Text] [Related]
54. Evidence that the nuclease activities associated with the herpes simplex type 1 DNA polymerase are due to the 3'-5' exonuclease.
Hall JD; Orth KL; Claus-Walker D
J Virol; 1996 Jul; 70(7):4816-8. PubMed ID: 8676514
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and characterization of a novel liver-targeted prodrug of cytosine-1-beta-D-arabinofuranoside monophosphate for the treatment of hepatocellular carcinoma.
Boyer SH; Sun Z; Jiang H; Esterbrook J; Gómez-Galeno JE; Craigo W; Reddy KR; Ugarkar BG; MacKenna DA; Erion MD
J Med Chem; 2006 Dec; 49(26):7711-20. PubMed ID: 17181153
[TBL] [Abstract][Full Text] [Related]
56. High expression of a 3'----5' exonuclease activity is specific to B lymphocytes.
Kenter AL; Tredup J
Mol Cell Biol; 1991 Sep; 11(9):4398-404. PubMed ID: 1875929
[TBL] [Abstract][Full Text] [Related]
57. Removal of anti-human immunodeficiency virus 2',3'-dideoxynucleoside monophosphates from DNA by a novel human cytosolic 3'-->5' exonuclease.
Skalski V; Liu SH; Cheng YC
Biochem Pharmacol; 1995 Sep; 50(6):815-21. PubMed ID: 7575643
[TBL] [Abstract][Full Text] [Related]
58. The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells.
Maggio SC; Rosato RR; Kramer LB; Dai Y; Rahmani M; Paik DS; Czarnik AC; Payne SG; Spiegel S; Grant S
Cancer Res; 2004 Apr; 64(7):2590-600. PubMed ID: 15059916
[TBL] [Abstract][Full Text] [Related]
59. Corticosteroid responsive fludarabine pulmonary toxicity.
Stoica GS; Greenberg HE; Rossoff LJ
Am J Clin Oncol; 2002 Aug; 25(4):340-1. PubMed ID: 12151960
[TBL] [Abstract][Full Text] [Related]
60. Exonuclease IX of Escherichia coli.
Shafritz KM; Sandigursky M; Franklin WA
Nucleic Acids Res; 1998 Jun; 26(11):2593-7. PubMed ID: 9592142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
